Delfi Diagnostics detects cancer early, when it is most curable, using high-precision non-invasive blood tests. It uses artificial intelligence and genome sequencing to detect unique patterns of DNA fragmentation in the blood of patients. The com...
DELFI Diagnostics is hiring an experienced assay and reagent development scientist to lead reagent specification, transfer, and validation for NGS-based liquid biopsy IVDs in Palo Alto.